EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia

Maria T Papadopoulou iD, Paraskevi Panagopoulou, Efstathia Paramera, Alexandros Pechlivanis, Christina Virgiliou iD, Eugenia Papakonstantinou iD, Maria Palabougiouki, Maria Ioannidou iD, Eleni Vasileiou, Athanasios Tragiannidis iD, Evangelos Papakonstantinou, Georgios Theodoridis iD und 2 weitere

Diagnostics · 24.03.2024 · 14 (7) · 682

DOI: 10.3390/diagnostics14070682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 24.03.2024. Verfasst von Maria T Papadopoulou und 13 weiteren Autor:innen. Beteiligte Einrichtung: 4th Pediatric Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Ring Road, Nea Efkarpia…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute lymphoblastic leukemia (ALL) is the most prevalent childhood malignancy. Despite high cure rates, several questions remain regarding predisposition, response to treatment, and prognosis of the disease. The role of intermediary metabolism in the individualized mechanistic pathways of the disease is unclear. We have hypothesized that children with any (sub)type of ALL have a distinct metabolomic fingerprint at diagnosis when compared: (i) to a control group; (ii) to children with a different (sub)type of ALL; (iii) to the end of the induction treatment. Materials and Methods: In this prospective case–control study (NCT03035344), plasma and urinary metabolites were analyzed in 34 children with ALL before the beginning (D0) and at the end of the induction treatment (D33). Their metabolic fingerprint was defined by targeted analysis of 106 metabolites and compared to that of an equal number of matched controls. Multivariate and univariate statistical analyses were performed using SIMCAP and scripts under the R programming language.

Results

Metabolomic analysis showed distinct changes in patients with ALL compared to controls on both D0 and D33. The metabolomic fingerprint within the patient group differed significantly between common B-ALL and pre-B ALL and between D0 and D33, reflecting the effect of treatment. We have further identified the major components of this metabolic dysregulation, indicating shifts in fatty acid synthesis, transfer and oxidation, in amino acid and glycerophospholipid metabolism, and in the glutaminolysis/TCA cycle.

Conclusions

The disease type and time point-specific metabolic alterations observed in pediatric ALL are of particular interest as they may offer potential for the discovery of new prognostic biomarkers and therapeutic targets.

Schlagwörter

Stichwörter der Autor:innen

amino acidsfatty acidsmetabolomicsorganic acidstherapeutic metabolic pathways

Autor:innen und Institutionen

  • 4th Pediatric Department, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Ring Road, Nea Efkarpia, 56403 Thessaloniki, Greece.
  • Woman-Mother-Child Hospital, University Hospitals of Lyon, 69500 Bron, France.
  • NEOLAB S.A., Medical Laboratory, 11527 Athens, Greece.
  • Department of Chemistry, Aristotle University of Thessaloniki, 54635 Thessaloniki, Greece.
  • BIOMIC_Auth, Center for Interdisciplinary Research of the Aristotle University of Thessaloniki (CIRI), Balkan Center, 10th Km Thessaloniki-Thermi Rd, P.O. Box 8318, 57001 Thessaloniki, Greece.
  • Analytical Chemistry Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

ORCID-Profile: Maria T Papadopoulou, Christina Virgiliou, Eugenia Papakonstantinou, Maria Ioannidou, Athanasios Tragiannidis, Georgios Theodoridis, Emmanuel Hatzipantelis, Athanasios Evangeliou

Zitieren

APA

Papadopoulou, M. T., Panagopoulou, P., Paramera, E., Pechlivanis, A., Virgiliou, C., Papakonstantinou, E., Palabougiouki, M., Ioannidou, M., Vasileiou, E., Tragiannidis, A., Papakonstantinou, E., Theodoridis, G., Hatzipantelis, E., & Evangeliou, A. (2024). Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia. Diagnostics, 14(7), 682. https://doi.org/10.3390/diagnostics14070682

Vancouver

Papadopoulou MT, Panagopoulou P, Paramera E, Pechlivanis A, Virgiliou C, Papakonstantinou E, et al. Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia. Diagnostics. 2024;14(7):682. doi:10.3390/diagnostics14070682

BibTeX
@article{Papadopoulou2024,
  author = {Papadopoulou, Maria T and Panagopoulou, Paraskevi and Paramera, Efstathia and Pechlivanis, Alexandros and Virgiliou, Christina and Papakonstantinou, Eugenia and Palabougiouki, Maria and Ioannidou, Maria and Vasileiou, Eleni and Tragiannidis, Athanasios and Papakonstantinou, Evangelos and Theodoridis, Georgios and Hatzipantelis, Emmanuel and Evangeliou, Athanasios},
  title = {Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {682},
  doi = {10.3390/diagnostics14070682}
}
Kostenlos starten →